TipRanks
Go Ultimate55% OFF

Immunovant (IMVT) Revenue

Immunovant Revenue

Revenue (ttm)
7.09M
Revenue Growth
―
P/S Ratio
―
Revenue/Employee
$0
Employees
315
Market Cap
$6.03B

Revenue Chart

Immunovant Revenue - Annual

00.511.52201820192020202120222023202420252026
Revenue History
Download to Excel
IMVT revenue history
Fiscal End DateRevenueChangeGrowth
Mar 31, 20260.000.00―
Mar 31, 20250.000.00―
Mar 31, 20240.000.00―
Mar 31, 20230.000.00―
Mar 31, 20220.000.00―
Mar 31, 20210.000.00―
Mar 31, 20200.000.00―
Mar 31, 20190.000.00―
Mar 31, 20180.00――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
IMVT7.09M
TGTX799.54M
VRDN71.13M
AUPH321.74M
PTGX281.99M
KYMR102.22M